NIKKEI 225
38,189.54 -216.12 (-0.56%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.13 -0.80 (-0.98%) GOLD FUTURES
2,297.50 -5.40 (-0.23%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
47,986.17 -3,122.70 (-6.11%)
Aurora Spine Corporation (ASG.V)
| Previous close | 0.2950 |
| Open | 0.2900 |
| Bid | 0.2750 x 0 |
| Ask | 0.2850 x 0 |
| Day's range | 0.2800 - 0.2900 |
| 52-week range | 0.2300 - 0.4650 |
| Volume | |
| Avg. volume | 13,340 |
| Market cap | 21.188M |
| Beta (5Y monthly) | 0.64 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2023 Financial Results
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for fiscal 2023 ended December 31, 2023. The company experienced strong, successive, quarter over quarter revenue growth, while overcoming early year o
- GlobeNewswire
Aurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
CARLSBAD, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants announced today that it has completed the second full year of implantation of the world’s first patient-bone-density matched interbody device, the cervical interbody DEXA-C. Trent Northcutt, CEO and President at Aurora Spine said, "It's a significant milestone for Aurora to celebrate the second anniversary of the
- GlobeNewswire
Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office
CARLSBAD, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its second United States Patent No: 11,850,162 entitled “Body Density Scan Result-Matched Orthopedic Implants and Methods of Use” for The World’s First DEXA Technology™ Patient-Matched Implant Technology. Aurora Spine’s first-of-its kind DEXA Techn
